BIIB

Biogen Inc

215.50

-3.55-1.62%

After Hours: 218.38 +2.88 +1.34%19:58 09/18 EDT

Daily

Weekly

Monthly

Quarterly

Yearly

OPEN/PREV CLOSE228.27/226.36

TODAY RANGE223.76-228.92

VOL407.00K

MARKET CAP33.69B

52 WEEK RANGE135.39-229.19

AVG VOL (3M)1.09M

% TURNOVER0.28%

TURNOVER--

P/E (TTM)40.38

% RANGE2.28%

EPS(TTM)5.65

P/E(FORWARD)37.19

P/B1.787

BVPS127.61

DIVIDEND--

P/S3.382

BETA--

DIV YIELD0.00%

FREE FLOAT MKT CAP33.54B

SHARES OUTSTANDING147.75M

NEXT EARNINGS10/28-11/02

FREE FLOAT147.10M

LOT SIZE1

EX-DATE02/02/2017

News

Press Releases

Financial Reports

Profile

TipRanks·1h ago
Analysts Conflicted on These Healthcare Names: Harmony Biosciences Holdings (HRMY), BioNTech SE (BNTX) and Biogen (BIIB)
NASDAQ·3d ago
CALF, EXPE, GDDY, BIIB: ETF Inflow Alert
NASDAQ·09/18 14:44
Weekly Buzz: RARE, BAYRY Win Approvals; SION Cuts Jobs, GSK Deals; AZN, RHHBY Lead
Seeking Alpha·09/18 11:08
Trump administration is said to weigh allowing most pharma licensing deals with China
TipRanks·09/18 10:50
Analysts Offer Insights on Healthcare Companies: Neuronetics (STIM), Xenon (XENE) and Biogen (BIIB)
NASDAQ·09/18 06:01
Biogen Publishes EMPAVELI Data Showing Reduced Proteinuria In Adolescents With Kidney Diseases
TipRanks·09/17 20:25
Biogen publishes results from adolescent subgroup of VALIANT study
Seeking Alpha·09/17 18:21
Looming biosimilar void risks $189B in lost U.S. healthcare savings: report
Seeking Alpha·09/17 11:15
Biogen: Growth Is Back, But It Came At A Price
Seeking Alpha·09/17 11:06
Roche succeeds in late-stage study for Lunsumio regimen in follicular lymphoma
NASDAQ·09/16 15:31
How AbbVie's Neuroscience Portfolio Has Transformed Over the Years
TipRanks·09/16 09:15
Eisai, Biogen announce Leqembi Pen has been approved in Japan
NASDAQ·09/16 06:50
Biogen And Eisai Announce Japan Approval Of LEQEMBI Pen To Treat Early Alzheimer's Disease
Seeking Alpha·09/14 12:00
Goldman rebalances its short duration stock basket
NASDAQ·09/12 21:01
Biogen Sees Pivotal Pipeline Moment as It Expands Beyond Neurology

Same Industry

Name/Symbol

Change%

Price

Biogen Inc

BIIB

-1.62%

215.50

MCK

Amgen Inc

AMGN

+1.55%

385.65

Bristol-Myers Squibb Company Celegne Contingent Value Rights

CELG-RT

+7.67%

0.1249

SHPG

Lilly Eli & Co

LLY

+1.04%

Celgene

CELG

0.00%

108.24

TXMD

Johnson & Johnson

JNJ

-0.09%

269.99

ABBV

Zoetis Inc

ZTS

-0.74%

70.87

Gilead Sciences Inc

GILD

-0.52%

150.11

NVO

Bristol-Myers Squibb Co

BMY

+0.35%

63.06

Alexion Pharms

ALXN

+1.70%

182.50

PFE

SNY

GCVRZ

Novartis

NVS

-0.39%

140.37

Dr Reddys Labs

RDY

0.00%

12.19

GSK PLC

GSK

-1.65%

50.22

No content on the Webull website shall be considered a recommendation or solicitation for the purchase or sale of securities, options or other investment products. All information and data on the website is for reference only and no historical data shall be considered as the basis for judging future trends.